Chemomab Therapeutics Ltd. - ADR earnings per share and revenue
On 17 de nov. de 2025, CMMB reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -0.01 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, 3 analistas forecast an EPS of -0.01 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were Chemomab Therapeutics Ltd. - ADR's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Chemomab Therapeutics Ltd. - ADR reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Chemomab Therapeutics Ltd. - ADR's Q3 2025 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Chemomab Therapeutics Ltd. - ADR expected to report next?
The next earning report is scheduled for 02 de mar. de 2026.
What are the forecasts for Chemomab Therapeutics Ltd. - ADR's next earnings report?
Based on 3
analistas, Chemomab Therapeutics Ltd. - ADR is expected to report EPS of -$0.01 and revenue of -- for Q4 2025.